{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:23:58Z","timestamp":1778253838233,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2656,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bbmt.2007.10.008","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T08:55:52Z","timestamp":1198659352000},"page":"23-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"S","title":["The Contribution of Endothelial Activation and Injury to End-Organ Toxicity following Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"14","author":[{"given":"Kenneth R.","family":"Cooke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Jannin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.10.008_bib1","first-page":"955","article-title":"Vascular endothelial lesions in patients undergoing bone marrow transplantation","volume":"18","author":"Richard","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib2","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood.V99.8.2940","article-title":"CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications","volume":"99","author":"Janin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1700767","article-title":"Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease","volume":"19","author":"Salat","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib4","first-page":"383","article-title":"Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation","volume":"18","author":"Testa","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib5","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation","volume":"89","author":"Salat","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib6","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","article-title":"Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation","volume":"73","author":"Holler","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00007890-199609270-00020","article-title":"Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo. Protective role of IL-10","volume":"62","author":"Eissner","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.10.008_bib8","first-page":"447","article-title":"Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro","volume":"138","author":"Robaye","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bbmt.2007.10.008_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.TP.0000128839.13674.02","article-title":"A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome","volume":"78","author":"Gerbitz","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.10.008_bib10","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1601","article-title":"Idiopathic pneumonia syndrome after bone marrow transplantation","volume":"147","author":"Clark","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.bbmt.2007.10.008_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00007890-199704270-00006","article-title":"Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation","volume":"63","author":"Kantrow","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.10.008_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/bbmt.2002.v8.pm12171486","article-title":"Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Yanik","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1703142","article-title":"Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation","volume":"28","author":"Afessa","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib14","first-page":"225","article-title":"Acute graft versus host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia","volume":"12","author":"Crawford","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib15","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2003-05-1597","article-title":"Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation","volume":"102","author":"Fukuda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib16","first-page":"101","article-title":"Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis","volume":"82","author":"Shankar","year":"2001","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.bbmt.2007.10.008_bib17","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI119612","article-title":"The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogenic recipients are due to donor T cell infusion and potentiated by cyclophosphamide","volume":"100","author":"Panoskaltsis-Mortari","year":"1997","journal-title":"J Clinl Invest"},{"key":"10.1016\/j.bbmt.2007.10.008_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/blood-2003-12-4259","article-title":"Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation","volume":"104","author":"Hildebrandt","year":"2004","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2007.10.008_bib20","first-page":"768a","article-title":"A role for Fas-Fas ligand but not perforin mediated cytolysis in the development of experimental idiopathic pneumonia syndrome","volume":"96","author":"Cooke","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib21","first-page":"863","article-title":"Diffuse alveolar hemorrhage associated with microangiopathy after allogeneic bone marrow transplantation","volume":"15","author":"Srivastava","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib22","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","article-title":"Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans","volume":"3","author":"Parikh","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.bbmt.2007.10.008_bib23","doi-asserted-by":"crossref","first-page":"104a","DOI":"10.1182\/blood.V104.11.354.354","article-title":"Survival following etanercept therapy for the treatment of idiopathic pneumonia syndrome following allogeneic stem cell transplantation","volume":"104","author":"Yanik","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib24","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/00007890-200211270-00020","article-title":"Endothelial cell early activation induced by allogeneic lymphocytes in isolated perfused mouse lung","volume":"74","author":"Joucher","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.10.008_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1593\/neo.05592","article-title":"Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer","volume":"8","author":"Goon","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbmt.2007.10.008_bib26","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/01.tp.0000209218.24916.ba","article-title":"Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients","volume":"81","author":"Pihusch","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.10.008_bib27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bbmt.2007.04.007","article-title":"Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Nachbaur","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.bmt.1705410","article-title":"Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation","volume":"38","author":"Min","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib29","first-page":"1821","article-title":"Elevation of plasminogen activator inhibitor-1 [PAI-1] levels in BMT-associated veno-occlusive disease [VOD] and changes seen with the use of defibrotide [DF]","volume":"88","author":"Richardson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(93)90864-E","article-title":"Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist","volume":"238","author":"Bianchi","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbmt.2007.10.008_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood.V100.1.334","article-title":"Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide","volume":"100","author":"Eissner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib32","first-page":"112A","article-title":"Defibrotide (DF) appears effective and safe in a phase II, randomized study of patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT)","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.008_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.02699.x","article-title":"The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation","volume":"113","author":"Fuge","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.10.008_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2007.10.008_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.10.008_bib36","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.bbmt.2007.02.009","article-title":"Stem cell transplantation nephropathy: a report of six cases","volume":"13","author":"Kersting","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib37","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1704512","article-title":"Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease","volume":"33","author":"Nishida","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0609.1989.tb00284.x","article-title":"Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation","volume":"43","author":"Cohen","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2007.10.008_bib40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","article-title":"Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.008_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-007-0631-0","article-title":"Two cases of refractory thrombotic thrombocytopenic purpura associated with collagen vascular disease were significantly improved by rituximab treatment","author":"Kameda","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.bbmt.2007.10.008_bib44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1160\/TH06-09-0499","article-title":"Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia","volume":"97","author":"Heidel","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bbmt.2007.10.008_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jca.20113","article-title":"Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura","volume":"22","author":"Patino","year":"2007","journal-title":"J Clin Apher"},{"key":"10.1016\/j.bbmt.2007.10.008_bib46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910700537X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910700537X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:30:29Z","timestamp":1761057029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387910700537X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S108387910700537X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.10.008","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Contribution of Endothelial Activation and Injury to End-Organ Toxicity following Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}